Treatment of clinical complications and intercurrences of cancer patients in the Brazilian Unified Health System
DOI:
https://doi.org/10.34019/1982-8047.2023.v49.42563Keywords:
Medical Oncology, Therapeutics, Unified Health System, EpidemiologyAbstract
Introduction: Cancer treatment can be a challenging experience for patients, especially when dealing with clinical complications. In Brazil, the Unified Health System (SUS) offers therapies and care to cancer patients, and it is necessary to investigate the amount of both over time. Objective: To evaluate the treatment for clinical complications and intercurrences related to cancer in the SUS between 2013 and 2021. Methods: An ecological study was carried out with data collected from the Hospital Information System (SIH/SUS). Two hospital procedures related to the treatment of clinical complications and intercurrences resulting from cancer were selected, examining the temporal tendency and the impact of the COVID-19 pandemic at a 5% significance level. Results: In the last nine years, more than two million procedures for complications and clinical intercurrences were carried out in the SUS. There was a significantly increasing tendency in the treatment of clinical complications (p = 0.001), while the treatment of intercurrences showed stationarity (p = 0.065). However, there was a significant reduction in the annual number during the first year of the COVID-19 pandemic, whether in the treatment of clinical complications (p <0.001) or intercurrences (p <0.001). At last, a significant, positive and moderate correlation was observed between both procedures in the SUS during the investigated period (p = 0.043, ρ = 0.700). Conclusion: The number of procedures to treat clinical complications of cancer patients in the SUS has increased in the last nine years, being reduced in 2020, during the COVID-19 pandemic.
Downloads
References
Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends: an update. Cancer Epidemiol Biomarkers Prev. 2016; 25(1):16-27. doi: 10.1158/1055-9965.EPI-15-0578.
Instituto Nacional de Câncer José Alencar Gomes da Silva (BR). Estimativa 2020: incidência de câncer no Brasil [Internet]. Rio de Janeiro: Ministério da Saúde; 2019 [citado em 2023 out 23]. Disponível em: https://www.gov.br/inca/pt-br.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71(3):209-49. doi: 10.3322/caac.21660.
Rivera DR, Gallicchio L, Brown J, Liu B, Kyriacou DN, Shelburne N. Trends in adult cancer-related emergency department utilization: an analysis of data from the nationwide emergency department sample. JAMA Oncol. 2017; 3(10):e172450. doi: 10.1001/jamaoncol.2017.2450.
Instituto Nacional de Câncer José Alencar Gomes da Silva (BR). Política nacional para prevenção e controle do câncer [Internet]. 2. ed. Rio de Janeiro: Ministério da Saúde; 2015 [citado em 2023 out 23]. Disponível em: https://www.gov.br/inca/pt-br.
Saxena A, Rubens M, Ramamoorthy V, Tonse R, Veledar E, McGranaghan P et al. Hospitalization rates for complications due to systemic therapy in the United States. Sci Rep. 2021; 11(1):7385. doi: 10.1038/s41598-021-86911-x.
Barak D, Gallo E, Rong K, Tang K, Du W. Experience of the COVID-19 pandemic in Wuhan leads to a lasting increase in social distancing. Sci Rep. 2022; 12(1):18457. doi: 10.1038/s41598-022-23019-w.
Araújo SEA, Leal A, Centrone AFY, Teich VD, Malheiro DT, Cypriano AS et al. Impact of COVID-19 pandemic on care of oncological patients: experience of a cancer center in a Latin American pandemic epicenter. Einstein (São Paulo). 2021; 19:eAO6282. doi: 10.31744/einstein_journal/2021AO6282.
Merchán-Hamann E, Tauil PL. Proposal for classifying the different types of descriptive epidemiological studies. Epidemiol Serv Saude. 2021; 30(1):e2018126. doi: 10.1590/s1679-49742021000100026.
Ministério da Saúde (BR). Resolução n° 510. De 7 de abril de 2016. Dispõe sobre as normas aplicáveis a pesquisas em ciências humanas e sociais. Diário Oficial da União. 2016 Mai 24; Sec. 1:44.
Ministério da Saúde (BR). Departamento de Informática: Sistema Único de Saúde (DATASUS) [Internet]. Brasília: Ministério da Saúde; 2023 [citado em 2023 out 23]. Disponível em: https://datasus.saude.gov.br/.
Malta M, Cardoso LO, Bastos FI, Magnanini MM, Silva CM. STROBE initiative: guidelines on reporting observational studies. Rev Saude Publica. 2010; 44(3):559-65. doi: 10.1590/S0034-89102010000300021.
Ministério da Saúde (BR). Portaria n° 420, de 25 de agosto de 2010. Dispõe sobre a tabela de procedimentos, medicamentos, órteses/próteses e materiais especiais do Sistema Único de Saúde. Diário Oficial da União. 2010 ago 26; cec. 1:81.
Latorre MRDO, Almeida ABM, Möller BB, Silva TGV, Toporcov TN. A importância do registro de câncer no planejamento em saúde. Rev USP. 2021; 1(128):27-44. doi: 10.11606/issn.2316-9036.i128p27-44.
Bittencourt SA, Camacho LAB, Leal MC. Hospital Information Systems and their application in public health. Cad Saude Publica. 2006; 22(1):19-30. doi: 10.1590/s0102-311x2006000100003.
Lemos C, Chaves LDP. Production of hospitalization in the Unified Health System in the region of Ribeirão Preto, Brazil. Rev Gaucha Enferm. 2011; 32(4):727-35. doi: 10.1590/S1983-14472011000400013.
Pagano M, Gauvreau K, Heather M. Principles of bioestatistics. 3. ed. Boca Raton: CRC Press; 2022.
Latorre MRDO, Cardoso MRA. Time series analysis in epidemiology: an introduction to methodological aspects. Rev Bras Epidemiol. 2001; 4(3):145-52. doi: 10.1590/S1415-790X2001000300002.
Antunes JLF, Cardoso MRA. Using time series analysis in epidemiological studies. Epidemiol Serv Saude. 2015; 24(3):565-76. doi: 10.5123/S1679-49742015000300024.
Schilsky RL, Nass S, Le Beau MM, Benz EJ Jr. Progress in cancer research, prevention, and care. N Engl J Med. 2020; 383(10):897-900. doi: 10.1056/NEJMp2007839.
Atty ATM, Tomazelli J, Dias MBK, Ribeiro CM. Impacto da pandemia da COVID-19 no diagnóstico do câncer de boca no Brasil. Rev Bras Cancerol. 2022; 68(4):e-042675. doi: 10.32635/2176-9745.RBC.2022v68n4.2675.
Malta DC, Gomes CS, Silva AGD, Cardoso LSM, Barros MBA, Lima MG et al. Use of health services and adherence to social distancing by adults with Noncommunicable Diseases during the COVID-19 pandemic, Brazil, 2020. Cien Saude Colet. 2021; 26(7):2833-2842. doi: 10.1590/1413-81232021267.00602021.
Luciani S, Caixeta R, Chavez C, Ondarsuhu D, Hennis A. What is the NCD service capacity and disruptions due to COVID-19? Results from the WHO non-communicable disease country capacity survey in the Americas region. BMJ Open. 2023; 13(3):e070085. doi: 10.1136/bmjopen-2022-070085.
Ribeiro CM, Correa FM, Migowski A. Short-term effects of the COVID-19 pandemic on cancer screening, diagnosis and treatment procedures in Brazil: a descriptive study, 2019-2020. Epidemiol Serv Saude. 2022; 31(1):e2021405. doi: 10.1590/S1679-49742022000100010.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Matheus Sanjuan Netis Teles Cardoso, Gabriel Emílio Dias Santos, Erik Abrahão Santos, Simone Yuriko Kameo, Ricardo Barbosa-Lima, Thiago da Silva Mendes
This work is licensed under a Creative Commons Attribution 4.0 International License.
Cessão de Primeira Publicação à HU Revista
Os autores mantém todos os direitos autorais sobre a publicação, sem restrições, e concedem à HU Revista o direito de primeira publicação, com o trabalho licenciado sob a Licença Creative Commons Attribution que permite o compartilhamento irrestrito do trabalho, com reconhecimento da autoria e crédito pela citação de publicação inicial nesta revista, referenciando inclusive seu DOI.
